Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four–Month Randomized, Double-Blind, Double-Dummy Trial

Autor: Peter W. Butler, Osvaldo D. Messina, Jonathan D. Adachi, Ronald Emkey, Kenneth G. Saag, J. Morales-Torres, Willem F. Lems, Xiang Yin, Nicola Pannacciulli, Piet Geusens

Publikováno v: Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis and Rheumatology, 71(7), 1174-1184. John Wiley and Sons Ltd
Arthritis & Rheumatology, 71(7), 1174-1184. Wiley
Saag, K G, Pannacciulli, N, Geusens, P, Adachi, J D, Messina, O D, Morales-Torres, J, Emkey, R, Butler, P W, Yin, X & Lems, W F 2019, ' Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four–Month Randomized, Double-Blind, Double-Dummy Trial ', Arthritis and Rheumatology, vol. 71, no. 7, pp. 1174-1184 . https://doi.org/10.1002/art.40874

Objective: Clinical trial results have shown that, in glucocorticoid-treated patients, treatment with denosumab 60 mg subcutaneously once every 6 months (Q6M) increased spine and hip bone mineral density (BMD) at month 12 significantly more than trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18fd7bfc48ab9cd640ffc5de83ae8bb8
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067689080&origin=inward

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of nutrition on muscle mass, strength, and performance in older adults

Autor: Noriko Yoshimura, D. A. Wahl, P. Burckhardt, Steven Boonen, Jean-Philippe Bonjour, Ambrish Mithal, J. Morales Torres, René Rizzoli, Robert G. Josse, G. El Hajj Fuleihan, Hans Degens, Cyrus Cooper, Paul Lips, Bess Dawson-Hughes

Publikováno v: Mithal, A, Bonjour, J P, Boonen, S, Burckhardt, P, Degens, H, Fuleihan, G E, Josse, R, Lips, P T A M, Torres, J M, Rizzoli, R, Yoshimura, N, Wahl, D A, Cooper, C & Dawson-Hughes, B 2013, ' Impact of nutrition on muscle mass, strength, and performance in older adults ', Osteoporosis International, vol. 24, no. 5, pp. 1555-1566 . https://doi.org/10.1007/s00198-012-2236-y
Osteoporosis International, 24(5), 1555-1566. Springer London
Osteoporosis International, Vol. 24, No 5 (2013) pp. 1555-1566

Muscle strength plays an important role in determining risk for falls, which result in fractures and other injuries. While bone loss has long been recognized as an inevitable consequence of aging, sarcopenia-the gradual loss of skeletal muscle mass a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::882c376a9a66561b4e6757700267500d
https://doi.org/10.1007/s00198-012-2236-y

IOF position statement: vitamin D recommendations for older adults

Autor: P. Burckhardt, Ambrish Mithal, Steven Boonen, Robert G. Josse, J. Morales-Torres, Bess Dawson-Hughes, Paul Lips, Jean-Philippe Bonjour, Ghada El-Hajj Fuleihan, Noriko Yoshimura

Publikováno v: Osteoporosis International, 21(7), 1151-1154. Springer London
Dawson-Hughes, B, Mithal, A, Bonjour, J P, Boonen, S, Burckhardt, P, Fuleihan, G E, Josse, R G, Lips, P T A M, Morales-Torres, J & Yoshimura, N 2010, ' IOF position statement: vitamin D recommendations for older adults ', Osteoporosis International, vol. 21, no. 7, pp. 1151-1154 . https://doi.org/10.1007/s00198-010-1285-3

This position paper of the International Osteoporosis Foundation makes recommendations for vitamin D nutrition in elderly men and women from an evidence-based perspective. © 2010 International Osteoporosis Foundation and National Osteoporosis Founda

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd991ea7d5695df5ab72418b24fd6729
https://doi.org/10.1007/s00198-010-1285-3

Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial

Autor: Gabriel Medrano-Ramírez, J. Morales-Torres, Ruben Burgos-Vargas, Nicholas Straniero, Elliott B. Grossbard, Ara Dikranian, Michael E. Weinblatt, Angela V. Vicente-Gonzales, Theresa K. Musser, Frederick T. Murphy, Arthur Kavanaugh

Publikováno v: Arthritis & Rheumatism. 58:3309-3318

Objective Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ-activating receptors. R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a2c492a32e3c64e8616c6a12d54d3bf
https://doi.org/10.1002/art.23992